By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Laboratory Corporation of America said today it has extended its tender offer for Orchid Cellmark.

The tender offer was originally set to expire on Tuesday, but now will expire on June 1, 6 p.m. EDT.

The company also said that it has received a request from the US Federal Trade Commission for additional information concerning its $85.4 million purchase of Orchid.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.